Pancreatic Cancer Research

ResearcherKanazawa UniversityActive in the last 2 years

Tuyen Thuy Bich Ho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5161-338X; OpenAlex author ID A5018246692. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer. Co-author DOI 10.1002/1878-0261.13796↗
  2. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer … Co-author DOI 10.1136/jitc-2020-001367↗
  3. Distinct chemotherapy-associated anti-cancer immunity by myeloid cells inhibition in murine pancreatic cancer models. Co-author DOI 10.1111/cas.13944↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuichi Kaneko · 3 shared papers, 2019–2025 · strength 0.42
  2. Taro Yamashita · 3 shared papers, 2019–2025 · strength 0.42
  3. Yoshio Sakai · 3 shared papers, 2019–2025 · strength 0.42
  4. Alessandro Nasti · 3 shared papers, 2019–2025 · strength 0.42
  5. Akihiro Seki · 2 shared papers, 2020–2025 · strength 0.35
  6. Takuya Komura · 2 shared papers, 2019–2020 · strength 0.17
  7. Masaki Miyazawa · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.